MREO

Mereo BioPharma (MREO)

Mereo BioPharma Group PLC

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MREO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/30	20 : 30	GlobeNewswire Inc.	Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/05/28	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/05/24	10 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/05/24	07 : 38	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/05/24	05 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/05/16	05 : 49	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/05/16	05 : 19	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/05/16	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/05/16	05 : 01	GlobeNewswire Inc.	Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/04/03	20 : 30	GlobeNewswire Inc.	Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/03/28	05 : 01	GlobeNewswire Inc.	Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/03/05	21 : 30	GlobeNewswire Inc.	Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/02/10	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/02/10	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/02/10	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/02/10	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/02/07	06 : 15	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/27	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/27	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/24	06 : 16	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/08	21 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/08	21 : 00	GlobeNewswire Inc.	Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/03	06 : 20	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/03	06 : 17	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/03	06 : 16	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/03	06 : 15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/03	06 : 15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/03	06 : 15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2024/01/03	06 : 15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MREO	Mereo BioPharma Group PLC
2023/12/19	06 : 16	Edgar (US Regulatory)	Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]	NASDAQ:MREO	Mereo BioPharma Group PLC